Visualitza VHIO - Articles científics per autor "Fakih, Marwan"
Ara mostrant els elements 1-7 d 7
-
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
Fucà, Giovanni; Cohen, Romain; Shitara, Kohei; Elez Fernandez, Mª Elena; Diez Garcia, Marc; Fakih, Marwan; Lonardi, Sara (BMJ, 2022-02) -
BRAFV600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Colle, Raphael; Lonardi, Sara; Cachanado, Marine; overman, michael; Elez, Elena; Fakih, Marwan (Oxford University Press, 2023-09-07) -
Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial
Fakih, Marwan; Prager, M.D., Gerald; Van Cutsem, Eric; Tabernero, Josep; taieb, julien; Ciardiello, Fortunato (Elsevier, 2024-03) -
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines
Grothey, Axel; Tabernero Caturla, Josep; Fakih, Marwan (Elsevier, 2021-08) -
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Corti, Francesca; Infante, Gabriele; Elez Fernandez, Mª Elena; Ros Montañá, Fco. Javier; Fakih, Marwan; Pietrantonio, Filippo; Lonardi, Sara (BMJ, 2021-08) -
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors
Luke, Jason; Fakih, Marwan; Schneider, Charles; Chiorean, E. Gabriela; Bendell, Johanna; Kristeleit, Rebecca; Brana, Irene (Springer Nature, 2023-06) -
Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design
Tabernero Caturla, Josep; Prager, Gerald W; Leger, Catherine; Fakih, Marwan; Taieb, Julien; Ciardiello, Fortunato (Future Medicine, 2021-06)